Published in J Infect Dis on July 01, 1991
Laboratory techniques in the diagnosis of herpes simplex infection. Genitourin Med (1993) 1.15
In vitro antibody secretion by peripheral blood mononuclear cells as an expression of the immune response to Brucella spp. in humans. J Clin Microbiol (1992) 0.86
Secretion of Toxoplasma gondii-specific antibody in vitro by peripheral blood mononuclear cells as a new marker of acute toxoplasmosis. Clin Exp Immunol (1992) 0.77
The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus-positive patients. Proc Natl Acad Sci U S A (1993) 2.94
Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann Intern Med (1983) 2.45
CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. J Infect Dis (2000) 2.34
Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin Microbiol (1999) 2.30
Optimized PCR using patient blood samples for diagnosis and follow-up of visceral Leishmaniasis, with special reference to AIDS patients. J Clin Microbiol (2000) 2.12
Fixation of split anterior tibialis tendon transfer by anchorage to the base of the 5th metatarsal bone. Orthop Traumatol Surg Res (2012) 1.96
Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer (2006) 1.94
Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose. Infect Control Hosp Epidemiol (2001) 1.88
Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Med Virol (1996) 1.77
Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol (2000) 1.70
[Acquired cytomegalovirus infections in immunocompetent adults: 116 cases]. Presse Med (1998) 1.63
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol (2004) 1.56
Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg (1995) 1.51
Comparison of various sample preparation methods for PCR diagnosis of visceral leishmaniasis using peripheral blood. J Clin Microbiol (2001) 1.50
Studies on the immune protection to murine experimental brucellosis conferred by Brucella fractions. I. Positive role of immune serum. Immunology (1978) 1.48
Antiretroviral treatment French guidelines 2013: economics influencing science. J Antimicrob Chemother (2014) 1.45
Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J Virol Methods (2005) 1.45
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J Clin Microbiol (1995) 1.44
CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. AIDS (2001) 1.38
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis (2008) 1.35
Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.34
Chikungunya outbreak in Montpellier, France, September to October 2014. Euro Surveill (2015) 1.30
'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients. HIV Med (2010) 1.28
Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J Infect Dis (1995) 1.25
Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br J Dermatol (2009) 1.23
In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J Gen Virol (1998) 1.23
Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model. Antimicrob Agents Chemother (1996) 1.22
Whole blood capcellia CD4/CD8 immunoassay for enumeration of CD4+ and CD8+ peripheral T lymphocytes. Clin Chem (1999) 1.19
[Comparison of the chemical composition a lipopolysaccharide fraction and of a polysaccharide fraction isolated from Brucella melitensis]. Eur J Biochem (1969) 1.18
A highly sensitive and rapid procedure for direct PCR detection of Leishmania infantum within human peripheral blood mononuclear cells. Acta Trop (1995) 1.16
Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz. HIV Med (2003) 1.15
[Immunological properties of a phenol-insoluble extract from Brucella melitensis (P.I. fraction)]. Ann Inst Pasteur (Paris) (1967) 1.15
Bacille Calmette-Guérin adenitis 30 years after immunization in a patient with AIDS. J Infect Dis (1989) 1.14
Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease. AIDS (1998) 1.09
Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells. J Immunol (2000) 1.09
Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy. J Clin Microbiol (1998) 1.08
[Anti-brucellosis human vaccination with an antigenic fraction of Brucella melitensis]. Bull Acad Natl Med (1970) 1.08
Stimulating activity of Brucella fractions in a human lymphocyte transformation test. Correlation with humoral and cellular immunity. Immunology (1976) 1.08
Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women. Sex Transm Infect (2008) 1.08
Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia. Diabetes Metab (2002) 1.07
X g and X chromosome inactivation. Lancet (1971) 1.06
HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM). Tissue Antigens (1982) 1.04
Management of sudden psychiatric disorders related to efavirenz. AIDS (2001) 1.04
Predicting physical activity change in men and women in two New England communities. Am J Prev Med (1993) 1.03
Visceral leishmaniasis in HIV-infected patients in the south of France. Bull World Health Organ (1995) 1.02
Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. J Immunol (1993) 1.01
Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances. Infect Immun (1976) 0.99
Body stature as a risk factor for diabetic sensory neuropathy. Am J Med (1986) 0.99
[Rickettsiaceae infections and fluoroquinolones]. Pathol Biol (Paris) (1988) 0.97
Genetic structure of Candida glabrata populations in AIDS and non-AIDS patients. J Clin Microbiol (2002) 0.97
Blood pressure, insulin, and glycemia in nondiabetic subjects. Am J Med (1986) 0.97
Vaccines, vaccination in brucellosis. Ann Inst Pasteur Microbiol (1987) 0.95
High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. HIV Med (2009) 0.94
Response of high and low antibody producer to Brucella. Ann Immunol (Paris) (1979) 0.93
Analysis of the spontaneous in vitro anti-HIV-1 antibody secretion by peripheral blood mononuclear cells in HIV-1 infection. Clin Exp Immunol (1991) 0.93
Lymphocyte response to P.H.A. in patients with lung cancer. Lancet (1970) 0.92
Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake. Eur J Clin Microbiol Infect Dis (2011) 0.90
Fixation of distal radius fractures in adults: a review. Orthop Traumatol Surg Res (2013) 0.90
Spondylodiscitis due to Bacteroides fragilis: two cases and review. Scand J Infect Dis (2006) 0.90
Cytomegalovirus-specific B cell activation as a potential marker for the diagnosis of cytomegalovirus infection. Eur J Clin Microbiol Infect Dis (1990) 0.90
[On the high frequency of anti-A and anti-B antibodies of high titer in American Indian tribes. Possible role as a selective factor]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.89
[Lymphography in ankylosing spondylarthritis]. J Radiol Electrol Med Nucl (1969) 0.89
In-vitro secretion of HIV-specific antibodies by peripheral blood cells. Lancet (1988) 0.88
Herpesvirus 6 infection in young children. N Engl J Med (1992) 0.87
Risk of cytomegalovirus transmission by cryopreserved semen: a study of 635 semen samples from 231 donors. Hum Reprod (2003) 0.87
Increased oxidative metabolism in PMA-activated lymphocytes: a flow cytometric study. Int J Immunopharmacol (1992) 0.87
Concomitant human infection due to Rickettsia conorii and Coxiella burnetii. J Infect Dis (1989) 0.87
Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity? Atherosclerosis (2003) 0.87
Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina Faso. Sex Transm Infect (2007) 0.87
Haemoculture as a tool for diagnosing visceral leishmaniasis in HIV-negative and HIV-positive patients: interest for parasite identification. Bull World Health Organ (1998) 0.86
Studies on the genetic control of murine humoral response to immunization with a peptidoglycan-containing fraction extracted from Brucella melitensis. Ann Immunol (Paris) (1980) 0.86
Antibody responses against polypeptide components of Epstein-Barr virus-induced early diffuse antigen in patients with connective tissue diseases. J Med Virol (1990) 0.86
Hypersensitivity related to abacavir in two members of a family. Ann Pharmacother (2001) 0.86
Antibodies against polypeptides of purified Epstein-Barr virus in sera from patients with connective tissue diseases. J Autoimmun (1992) 0.86
In vitro antibody secretion by peripheral blood mononuclear cells as an expression of the immune response to Brucella spp. in humans. J Clin Microbiol (1992) 0.86
Cytotoxicity of A.L.S. and anti-HL-A antibodies in human leukaemia. Lancet (1972) 0.86
Relationship between Hassall's corpuscles and thymocytes fate in guinea-pig foetus. Biomedicine (1976) 0.85
Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection. Liver Transpl Surg (1997) 0.85
Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. Nephrol Dial Transplant (1994) 0.85
Dual action of erbium on transmitter release at the frog neuromuscular synapse. Nature (1978) 0.85